DM-BOOST Para Latinx: a Diabetes Mellitus Program Using Behavioral Economics to Optimize Outreach and Self-management Support With Technology for Latinx Patients

Daniel Amante20 enrolled

Overview

The specific aims of this project are to culturally adapt the DM-BOOST intervention for Latinx patients, usability test 'DM-BOOST para Latinx' to optimize cultural appropriateness and patient engagement and conduct a feasibility evaluation of DM-BOOST para Latinx. These aims will be accomplished via a community-based participatory research approach in collaboration with clinical, community and patient partners. This project will inform subsequent proposals to evaluate implementation of DM-BOOST in the UMass Memorial Health Care system.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Enrollment

Conditions

Diabetes Mellitus, Type 2

Interventions

Diabetes BOOST

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Aims 1 and 2 Patient Inclusion Criteria: * Age \> 18 years * Diagnosis of type 2 diabetes * Identifies as Hispanic/Latinx * Spanish language preference Aims 1 and 2 Patient Exclusion Criteria: * Cognitive impairment * Current prisoner * Pregnant women Aim 3 Patient Inclusion Criteria: * Age \> 18 years * Diagnosis of type 2 diabetes * Identifies as Hispanic/Latinx * Spanish language preference Aim 3 Patient Exclusion Criteria: * Cognitive impairment * Current prisoner * Pregnant women * Completed DSMT in previous year

Locations (2)

UMass Memorial health

Worcester, Massachusetts, United States

University of Massachusetts Medical School

Worcester, Massachusetts, United States

Outcomes

Primary Outcomes

Process Evaluation

Evaluate engagement by examining the number of DSMT appointments scheduled, cancellation/no show rates and total number of DSMT-related encounters completed.

Time frame: 3 - 6 months

Secondary Outcomes

Diabetes self-efficacy

Diabetes self efficacy will be measured at baseline and 3 months after enrolling in the study using the Diabetes Management Self-Efficacy Scale. Participants will provide feedback on set of questions, using a 5-point Likert scale( with 1=Strong Disagree, 2=Somewhat Disagree, 3= Neutral, 4=Somewhat Agree, 5= Strongly Agree)

Time frame: 3 months

Diabetes treatment satisfaction

Diabetes Treatment Satisfaction will be measured at 3 months after enrolling in the study using the Diabetes Treatment Satisfaction Questionnaire Change tool. Participants will be asked to share how their experience of current treatment has changed from their experience of treatment before the study began. They will answer each question by choosing 3 for Much More Satisfied Now up to -3 for Much Less Satisfied Now. (3,2,1,0,-1,-2,-3)

Time frame: 3 months

Change in HbA1c Percentage

Measurement of HbA1c values to determine impact of intervention. HbA1c values at baseline visit will be compared with values at 3-6 months after participant's enrollment. These data will be obtained through EHR chart review.

Time frame: 6 months